Ads
related to: acute leukemia in adults- About AML
What Is AML
AML Treatment
- Oral Treatment
That You Can Take At Home
Find Out More
- Download Patient Info
View Patient Assistance Resources
Register to Learn More
- Register for More Info
Receive Patient Resources
Get Additional Support
- Treatment Safety
Possible Side Effects
Important Safety Info
- View Patient Information
Download Patient Brochures
Learn More
- About AML
Search results
Rgenta Therapeutics Presents Preclinical Data from Lead Program RGT-61159, a Potent Inhibitor of...
The Woonsocket Call· 6 days ago"The data presented at ASCO 2024 demonstrate efficient and specific modulation of the oncogenic transcription factor MYB, a target that historically has been difficult to drug, by RGT-61159 ...
Eldridge family establishes hospital fund to help other families of children with cancer
Quad-City Times· 7 days agoHudson McKearney is a 7-year-old boy who loves superheroes. Just before his second birthday,...
Gilead's (GILD) Urothelial Cancer Study Did Not Meet Its Primary Goal
Zacks via Yahoo Finance· 5 days agoGilead Sciences, Inc.'s (GILD) confirmatory TROPiCS-04 study on Trodelvy in locally advanced or...
Small Business - Shelby County Reporter | Shelby County Reporter
The Shelby County Reporter· 2 days agoLive from ASCO 2024 | Updated Data of Bcl-2 Inhibitor Lisaftoclax Combined with Azacitidine in Patients with AML Demonstrate Promising Efficacy and Manageable Safety PR Newswire SUZHOU, China ...
Small Business - Shelby County Reporter | Shelby County Reporter
The Shelby County Reporter· 22 hours agoLive from ASCO 2024 | Oral Report Released Latest Data of Olverembatinib in SDH-Deficient GIST, Including a CBR of 92.3% PR Newswire SUZHOU, China and ROCKVILLE, Md., June 4, 2024 SUZHOU, China ...
New Gene Tests Can Predict if a Drug Will Work for a Patient
Medscape· 6 days agoWhat if there were tests that could tell you whether the following drugs were a good match for your...
Blenrep-Based Regimen Yields PFS Benefit in Relapsed/Refractory Myeloma
MedPage Today· 4 days agoProgression-free survival (PFS) was significantly higher with belantamab mafodotin (belamaf;...
Jasper Therapeutics to Present Data on Briquilimab in Mast Cell Driven Diseases at the EAACI...
Benzinga· 6 days agoREDWOOD CITY, Calif., May 30, 2024 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (NASDAQ:JSPR) (Jasper), a clinical stage biotechnology company focused on development of briquilimab, a novel antibody therapy targeting
Ad
related to: acute leukemia in adults